Argentum

Recent Posts

COVID-19 Booster Shots Targeting Omicron Authorized, Likely to Be Offered Soon

Posted by Argentum on August 31, 2022

U.S. health regulators cleared use of retooled Covid-19 vaccines that target the latest versions of Omicron, in preparation for a fall booster campaign that could start within days.

Read More

Topics: Vaccine

Preparing Your Staff and Residents for COVID and More This Fall

Posted by Argentum on August 29, 2022

Fall is a time for change. The leaves turn from green to vibrant shades of yellow, orange, and red. The air turns cooler and crispier. And, unfortunately, the risk of contracting COVID and influenza increases as people spend more time indoors. It's important to take precautions against these illnesses, especially for seniors living in senior living communities.

Read More

Moving Forward with Infection Prevention and Control

Posted by Argentum on August 19, 2022

Infection prevention and control is one of the most important aspects of senior living. As our population ages, the risk of infection increases, so it is important to have systems in place that protect our residents from illnesses and keep them healthy.

We have certainly been impressed by the innovation and creativity that came from two years of societal upheaval and now we are at a point in time where we, as an industry, can move forward. With new pathogens constantly emerging, Argentum is thrilled to announce that we are expanding the COVID-19 blog to include some of the latest research, news and advances in infection prevention and control.

Please share this blog with colleagues who may be interested in receiving infection prevention and control news and resources in their inboxes. Thanks for reading, and stay safe!

Read More

U.S. Reaches $1.74 Billion Deal With Moderna for Updated Covid-19 Shots

Posted by Argentum on July 29, 2022

The Biden administration said it would spend $1.74 billion to buy 66 million doses of Moderna Inc.’s updated Covid-19 vaccine, as well as the option to purchase up to 234 million additional doses, as part of a fall booster campaign.

Read More

Topics: Vaccine, Biden Administration

CDC Approves New COVID-19 Vaccine Novavax

Posted by Argentum on July 20, 2022

The U.S. Centers for Disease Control (CDC) approved the COVID-19 vaccine from Maryland-based vaccine maker Novavax, unlocking the 3.2 million doses that the U.S. government has purchased from Novavax for widespread distribution.

Read More

Topics: Vaccine

COVID Vaccines Saved 20 Million Lives in 1st Year, Scientists Say

Posted by Argentum on July 1, 2022
Researchers estimate that COVID-19 vaccines saved almost 20 million lives in their first year, although even more fatalities could have been prevented if international targets for the shots had been met, reports the Associated Press.
Read More

Topics: Vaccine

FDA Advisers Recommend Updated Boosters Targeting Forms of Omicron

Posted by Argentum on June 30, 2022

Instead of keeping with COVID-19 vaccine boosters that target the original strain of SARS-CoV-2, an FDA advisory panel said this week that it favors reformulating the doses to also work against newer Omicron subtypes, reports the New York Times.

Read More

Topics: Vaccine

COVID-19 Vaccinations Approved for Children as Young as 6 Months Old

Posted by Argentum on June 22, 2022

To the relief of many parents and caregivers, panels for the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) have determined that the known and potential benefits of vaccinating children 6 months of age and older outweigh the known and potential risks in the pediatric populations authorized for use for use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine. Vaccinations began this week.

Read More

Topics: Vaccine

FDA authorizes second booster shot for people age 50 and up

Posted by Argentum on March 29, 2022

The Food and Drug Administration (FDA) gave the green light on Tuesday, March 29 to a second coronavirus vaccine booster shot for people aged 50 and older in an effort to ward off another potential spike in infections due to a subvariant of omicron.

Read More

Topics: Vaccine

Moderna asks FDA to authorize second booster for adults

Posted by Argentum on March 18, 2022

Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its Covid-19 vaccine as a booster dose for all adults.

Read More

Topics: Vaccine

Subscribe to Instant Email Updates

See More COVID-19 Announcements

Read more announcements related to COVID-19 on our Coronavirus Blog and access more information on:

SEE BLOG

Stay Updated on COVID-19

Find all of our latest updates on developments related to COVID-19 on our Coronavirus Toolkit.

SEE TOOLKIT